Indian Journal of Endocrinology and Metabolism

: 1997  |  Volume : 1  |  Issue : 1  |  Page : 1--2

Radioablation In Graves Thyrotoxicosis

K. M Prasannakumar1, M Dharmalingam2 

Correspondence Address:
K. M Prasannakumar

A randomized study was done in 319 consective patients with Graves thyrotoxicosis who under went radioiodine ablation therapy. They were given 5 millicurie of 131 I. This group was compared to 106 patients given 6 millicurie 131 I. In the former group, 245 (79.62%) remained euthyroid after a mean of one year, 54 (16.92%) became hypothyroid and 11 (3.44%) needed a second dose of radioiodine. In the second group, 72% remained euthyroid, 25% became hypothroid and 1.9% required a repeat dose of radioiodine. In summary, fewer patients with 5 millicurie of radioiodine became hypothyroid after a follow up period of one year, and more remained euthyroid compared to those who received 6 millicurie radioiodine.

How to cite this article:
Prasannakumar K, Dharmalingam M. Radioablation In Graves Thyrotoxicosis.Indian J Endocr Metab 1997;1:1-2

How to cite this URL:
Prasannakumar K, Dharmalingam M. Radioablation In Graves Thyrotoxicosis. Indian J Endocr Metab [serial online] 1997 [cited 2020 Oct 21 ];1:1-2
Available from:;year=1997;volume=1;issue=1;spage=1;epage=2;aulast=Prasannakumar;type=0